Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$139K Sell
15,486
-361
-2% -$3.31K 0.02% 368
2026
Q1
$147K Sell
15,847
-6
-0% -$59 0.03% 313
2025
Q4
$111K Sell
15,853
-765
-5% -$4.81K 0.02% 304
2025
Q3
$94.9K Buy
16,618
+3,343
+25% +$17.8K 0.02% 291
2025
Q2
$63.5K Sell
13,275
-3,209
-19% -$18.4K 0.01% 273
2025
Q1
$143K Buy
+16,484
New +$173K 0.03% 248

Other funds holding NEOG

Sage Rhino Capital's NEOG Position: Q2 2026 in Review

Sage Rhino Capital reduced its Neogen (NEOG) stake by 2.3% in Q2 2026, selling an estimated $3.31K and leaving 15,486 shares worth $139K. The position accounts for 0.02% of the portfolio, ranked #368.

Sage Rhino Capital first reported a position in NEOG in Q1 2025 and has held it in 6 quarters since. The position peaked at $147K in Q1 2026. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Sage Rhino Capital held 15,486 shares of Neogen worth $139K as of Q2 2026.
  • Sage Rhino Capital sold 361 Neogen shares in Q2 2026, an estimated $3.31K.
  • Neogen made up 0.02% of Sage Rhino Capital's portfolio in Q2 2026, its #368 holding.
  • Sage Rhino Capital first reported a position in Neogen in Q1 2025 and has held it in 6 quarters since.
  • Sage Rhino Capital's Neogen position peaked at $147K in Q1 2026.
  • 317 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Sage Rhino Capital's 13F filing for Q2 2026, filed 3 Aug 2026.